Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
KRO · NYSE · United States · Industrial Inorganic Chemicals
In shortKRONOS WORLDWIDE INC is loss-making, burns cash and carries moderate debt, with revenue stable (−1.5% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -2.0% | 10/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -6.0% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -14.1% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | -2.2% | 0/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 2.70× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.74× | 70/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 21.84× | 0/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | -0.69× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 2.25 | 29/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -2.2% | 11/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 3 of 5 | 50/100 |
Weight in the score: 20%
| Profitable years (last 5) | 3 of 5 | 60/100 |
|---|---|---|
| Years of revenue decline (last 5) | 3 of 5 | 0/100 |
| Revenue growth volatility | 12.7% | 64/100 |
| Operating margin volatility | 6.0% | 54/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -1.2% | 10/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 1,939 | 1,930 | 1,667 | 1,887 | 1,859 |
| Cost of revenue | 1,493 | 1,539 | 1,502 | 1,528 | 1,646 |
| Gross profit | 446 | 391 | 165 | 359 | 213 |
| Research & development | 17 | 15 | 18 | 14 | 16 |
| Selling, general & admin | 249 | 231 | 211 | 226 | 245 |
| Operating income | 187 | 160 | (56) | 123 | (37) |
| Interest expense | 20 | 17 | 17 | 43 | 53 |
| Pre-tax income | 153 | 134 | (73) | 150 | (97) |
| Income tax | 41 | 29 | (24) | 63 | 14 |
| Net income | 113 | 105 | (49) | 86 | (111) |
| Diluted EPS | $0.98 | $0.90 | −$0.43 | $0.75 | −$0.96 |
| Diluted shares (millions) | 0 | 116 | 115 | 115 | 115 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
2.25 Grey zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 5, 2026